Results 211 to 220 of about 1,246,657 (288)

Review of Graphene Liquid Cell (In Situ TEM) for Battery Materials

open access: yesEcoEnergy, EarlyView.
This review outlines the principles, fabrication, and applications of graphene liquid‐cell TEM in battery research. GLC‐TEM enables real‐time, high‐resolution imaging while minimizing beam damage. Advances such as flow‐type designs, MEMS integration, and AI‐based analysis address current limitations, offering new opportunities for studying battery ...
Pendo Bigambo   +7 more
wiley   +1 more source

Amyloid-beta (1-40) peptide is associated with systemic metabolic health. [PDF]

open access: yesEur J Clin Invest
Sopova K   +12 more
europepmc   +1 more source

Oxygen Vacancy‐Engineered S‐Scheme FeOOH/Ov‐BiVO4 Heterojunction: Interfacial Charge Dynamics Optimization and Pathogenic Polypeptide Aggregates Degradation

open access: yesEcoEnergy, EarlyView.
By integrating interfacial oxygen vacancies and cone‐shaped FeOOH, a highly efficient S‐scheme FeOOH/Ov‐BiVO4 photoanode was constructed. This dual‐strategy significantly accelerates charge transfer and enhances reactant adsorption, achieving outstanding photoelectrochemical degradation of pathogenic amyloid β‐polypeptide aggregates.
Xinshang Li   +7 more
wiley   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang   +7 more
wiley   +1 more source

The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion protein. [PDF]

open access: yesNeurotherapeutics
Kafi MAA   +9 more
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

Prolonged morning wake transitions associated with amyloid beta burden: A cross-sectional pilot study. [PDF]

open access: yesAlzheimers Dement
von Fingerhut G   +6 more
europepmc   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy